Active Shortage

COLISTIMETHATE FOR INJECTION USP

MARCAN PHARMACEUTICALS INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of COLISTIMETHATE FOR INJECTION USP in Canada?

Yes. COLISTIMETHATE FOR INJECTION USP 150MG has an active shortage reported to Health Canada (last updated July 30, 2026).

When will COLISTIMETHATE FOR INJECTION USP be available again?

The manufacturer's estimated resolution date is October 31, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file1 product

Expected resolution~33 days remaining (estimate)

Affected strength150MG

Last updated2026-07-30

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

COLISTIMETHATE FOR INJECTION, USP

FRESENIUS KABI CANADA LTD

150MG · DIN 02403544

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2026-10-31

~33 days remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02546639

Strength

150MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS INTRAMUSCULAR

Active Ingredient

COLISTIMETHATE SODIUM

Tier

Unrated

Last Updated

2026-07-30

Reason for Shortage

Other (Please describe in comments)

Source

View original report on healthproductshortages.ca ↗

Other Products from MARCAN PHARMACEUTICALS INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAZOLAMIDE FOR INJECTION USP

500MG · DIN 02537893

AMIKACIN SULFATE INJECTION USP

500MG · DIN 02481073

ARSENIC TRIOXIDE FOR INJECTION

1MG · DIN 02554364

BICNU

100MG · DIN 00297763

BICNU

100MG · DIN 02555093

BORTEZOMIB FOR INJECTION

3.5MG · DIN 02493306